Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 10 June 1988:
Vol. 240. no. 4858, pp. 1546 - 1548
DOI: 10.1126/science.3259727
Prev | Table of Contents | Next

Articles

Science, Vol 240, Issue 4858, 1546-1548
Copyright © 1988 by American Association for the Advancement of Science

articles

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

H Vlassara, M Brownlee, KR Manogue, CA Dinarello, and A Pasagian

Laboratory of Medical Biochemistry, Rockefeller University, New York, NY 10021.

Proteins undergo a series of nonenzymatic reactions with glucose over time to form advanced glycosylation end products (AGEs). Macrophages have a receptor that recognizes the AGE moiety and mediates the uptake and degradation of AGE proteins. This removal process is associated with the production and secretion of cachectin (tumor necrosis factor) and interleukin-1, two cytokines with diverse and seemingly paradoxical biological activities. The localized release and action of these cytokines could account for the coordinated removal and replacement of senescent extracellular matrix components in normal tissue homeostasis.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The role of the receptor for advanced glycation end-products in lung fibrosis.
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya (2007)
Am J Physiol Lung Cell Mol Physiol 293, L1427-L1436
   Abstract »    Full Text »    PDF »
Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.
J. Treweek, S. Wee, G. F. Koob, T. J. Dickerson, and K. D. Janda (2007)
PNAS 104, 11580-11584
   Abstract »    Full Text »    PDF »
Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus.
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke (2007)
J. Immunol. 179, 647-654
   Abstract »    Full Text »    PDF »
Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.
B. Zhao, G. Smith, J. Cai, A. Ma, and M. Boulton (2007)
Br J Ophthalmol 91, 538-545
   Abstract »    Full Text »    PDF »
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways.
A. Tedgui and Z. Mallat (2006)
Physiol Rev 86, 515-581
   Abstract »    Full Text »    PDF »
The Pathobiology of Diabetic Complications: A Unifying Mechanism.
M. Brownlee (2005)
Diabetes 54, 1615-1625
   Full Text »    PDF »
Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways.
Z. Alikhani, M. Alikhani, C. M. Boyd, K. Nagao, P. C. Trackman, and D. T. Graves (2005)
J. Biol. Chem. 280, 12087-12095
   Abstract »    Full Text »    PDF »
Effects of Thalidomide on Intracellular Mycobacterium leprae in Normal and Activated Macrophages.
A. Tadesse and E. J. Shannon (2005)
Clin. Vaccine Immunol. 12, 130-134
   Abstract »    Full Text »    PDF »
Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression.
M.-C. Beauchamp, S.-E. Michaud, L. Li, M. R. Sartippour, and G. Renier (2004)
J. Lipid Res. 45, 1749-1757
   Abstract »    Full Text »    PDF »
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
G. Basta, A. M. Schmidt, and R. De Caterina (2004)
Cardiovasc Res 63, 582-592
   Abstract »    Full Text »    PDF »
Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance.
F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino (2004)
JAMA 291, 1857-1863
   Abstract »    Full Text »    PDF »
Glucose Enhances Human Macrophage LOX-1 Expression: Role for LOX-1 in Glucose-Induced Macrophage Foam Cell Formation.
L. Li, T. Sawamura, and G. Renier (2004)
Circ. Res. 94, 892-901
   Abstract »    Full Text »    PDF »
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes.
J. C. Pickup (2004)
Diabetes Care 27, 813-823
   Abstract »    Full Text »    PDF »
Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA.
J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes (2004)
Diabetes 53, 743-751
   Abstract »    Full Text »    PDF »
Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products.
N. Shanmugam, Y. S. Kim, L. Lanting, and R. Natarajan (2003)
J. Biol. Chem. 278, 34834-34844
   Abstract »    Full Text »    PDF »
Relation Between Serum 3-Deoxyglucosone and Development of Diabetic Microangiopathy.
H. Kusunoki, S. Miyata, T. Ohara, B.-F. Liu, A. Uriuhara, H. Kojima, K. Suzuki, H. Miyazaki, Y. Yamashita, K. Inaba, et al. (2003)
Diabetes Care 26, 1889-1894
   Abstract »    Full Text »    PDF »
Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier.
C. G. De Pasquale, A. D. Bersten, I. R. Doyle, P. E. Aylward, and L. F. Arnolda (2003)
Am J Physiol Heart Circ Physiol 284, H2136-H2145
   Abstract »    Full Text »    PDF »
Expression and Function of Receptors for Advanced Glycation End Products in Bovine Corneal Endothelial Cells.
Y. Kaji, S. Amano, T. Usui, T. Oshika, K. Yamashiro, S. Ishida, K. Suzuki, S. Tanaka, A. P. Adamis, R. Nagai, et al. (2003)
Invest. Ophthalmol. Vis. Sci. 44, 521-528
   Abstract »    Full Text »    PDF »
Optimizing renal replacement therapy--a case for online filtration therapies?.
C. H. Beerenhout, J. P. Kooman, A. J. Luik, S. G. J. Jeuken-Mertens, F. M. van der Sande, and K. M. L. Leunissen (2002)
Nephrol. Dial. Transplant. 17, 2065-2070
   Full Text »    PDF »
A previously undescribed chemical link between smoking and metabolic disease.
T. J. Dickerson and K. D. Janda (2002)
PNAS 99, 15084-15088
   Abstract »    Full Text »    PDF »
Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes.
R. Hayaishi-Okano, Y. Yamasaki, N. Katakami, K. Ohtoshi, S.-I. Gorogawa, A. Kuroda, M. Matsuhisa, K. Kosugi, N. Nishikawa, Y. Kajimoto, et al. (2002)
Diabetes Care 25, 1432-1438
   Abstract »    Full Text »    PDF »
Covalent modification of proteins by cocaine.
S.-X. Deng, N. Bharat, M. C. Fischman, and D. W. Landry (2002)
PNAS 99, 3412-3416
   Abstract »    Full Text »    PDF »
What is diabetic renal disease?.
H. Gallagher and P. A Andrews (2002)
The British Journal of Diabetes & Vascular Disease 2, 96-100
   Abstract »    PDF »
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules.
W. H. Horl (2002)
J. Am. Soc. Nephrol. 13, S62-71
   Abstract »    Full Text »    PDF »
Dual roles for HMGB1: DNA binding and cytokine.
C. J. Czura, Haichao Wang, and K. J. Tracey (2001)
Innate Immunity 7, 315-321
   Abstract »    PDF »
Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty.
Y Otsuka, S Miyazaki, H Okumura, S Yasuda, S Daikoku, I Morii, Y Sutani, Y Goto, and H Nonogi (2000)
Eur. Heart J. 21, 1790-1796
   Abstract »    PDF »
Local application of advanced glycation end products and intimal hyperplasia in the rabbit collared carotid artery.
H. M Crauwels, A. G Herman, and H. Bult (2000)
Cardiovasc Res 47, 173-182
   Abstract »    Full Text »    PDF »
Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms.
L.M. Golub, H.-M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, and T. Sorsa (1998)
Advances in Dental Research 12, 12-26
   Abstract »    PDF »
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease.
S. M. Haffner (1998)
Endocr. Rev. 19, 583-592
   Abstract »    Full Text »
Molecular cloning of genes differentially regulated by TNF-{alpha} in bovine aortic endothelial cells, fibroblasts and smooth muscle cells.
J. Lin, B. Liliensiek, M. Kanitz, U. Schimanski, H. Bohrer, R. Waldherr, E. Martin, G. Kauffmann, R. Ziegler, and P. P. Nawroth (1998)
Cardiovasc Res 38, 802-813
   Abstract »    Full Text »    PDF »
Clusters of Perifollicular Macrophages in Normal Murine Skin: Physiological Degeneration of Selected Hair Follicles by Programmed Organ Deletion.
S. Eichmüller, C. van der Veen, I. Moll, B. Hermes, U. Hofmann, S. Müller-Röver, and R. Paus (1998)
J. Histochem. Cytochem. 46, 361-370
   Abstract »    Full Text »
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.
A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth (1998)
Cardiovasc Res 37, 586-600
   Abstract »    Full Text »    PDF »
Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome.
C. Grunfeld, W. Doerrler, M. Pang, P. Jensen, K. H. Weisgraber, and K. R. Feingold (1997)
J. Clin. Endocrinol. Metab. 82, 3734-3740
   Abstract »    Full Text »    PDF »
Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes : Role of Oxidant Stress and Protein Tyrosine Kinase Activation.
F. Khechai, V. Ollivier, F. Bridey, M. Amar, J. Hakim, and D. de Prost (1997)
Arterioscler Thromb Vasc Biol 17, 2885-2890
   Abstract »    Full Text »
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE.
A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth (1997)
Circulation 96, 2262-2271
   Abstract »    Full Text »
Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes.
S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga (1997)
J. Biol. Chem. 272, 4037-4042
   Abstract »    Full Text »    PDF »
Macrophages induce apoptosis in normal cells in vivo.
G Diez-Roux and R. Lang (1997)
Development 124, 3633-3638
   Abstract »    PDF »
Protein Cross-linking by the Maillard Reaction. ISOLATION, CHARACTERIZATION, AND IN VIVO DETECTION OF A LYSINE-LYSINE CROSS-LINK DERIVED FROM METHYLGLYOXAL.
R. H. Nagaraj, I. N. Shipanova, and F. M. Faust (1996)
J. Biol. Chem. 271, 19338-19345
   Abstract »    Full Text »    PDF »
Cerebroprotective Effects of Aminoguanidine in a Rodent Model of Stroke.
K. M. Cockroft, M. Meistrell III, G. A. Zimmerman, D. Risucci, O. Bloom, A. Cerami, K. J. Tracey, and G. Feuerstein (1996)
Stroke 27, 1393-1398
   Abstract »    Full Text »
Wall Thickening of Common Carotid Arteries in Patients Affected by Noninsulin-Dependent Diabetes Mellitus: Relationship to Microvascular Complications.
A. Visona, L. Lusiani, A. Bonanome, G. Beltramello, L. Confortin, B. Papesso, F. Costa, and A. Pagnan (1995)
Angiology 46, 793-799
   Abstract »    PDF »
Matrix Nonenzymatic Glycosylation Leads to Altered Cellular Phenotype and Intracellular Tyrosine Phosphorylation.
G. Hasegawa, A. J. Hunter, and A. S. Charonis (1995)
J. Biol. Chem. 270, 3278-3283
   Abstract »    Full Text »    PDF »
Invited Review: Cytokine Mediators of Malnutrition: Clinical Implications.
T. C. Hardin (1993)
Nutr Clin Pract 8, 55-59
   Abstract »    PDF »
Prevalence of, and Risk Factors for, Angiographically Determined Coronary Artery Disease in Type I-Diabetic Patients With Nephropathy.
C. L. Manske, R. F. Wilson, Y. Wang, and W. Thomas (1992)
Arch Intern Med 152, 2450-2455
   Abstract »    PDF »
Hemoglobin-AGE: a circulating marker of advanced glycosylation.
Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala (1992)
Science 258, 651-653
   Abstract »    PDF »
Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta.
T. Sutter, K Guzman, K. Dold, and W. Greenlee (1991)
Science 254, 415-418
   Abstract »    PDF »
CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products.
N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama (2001)
J. Biol. Chem. 276, 3195-3202
   Abstract »    Full Text »    PDF »
Early Glycation Products Produce Pentosidine Cross-links on Native Proteins. NOVEL MECHANISM OF PENTOSIDINE FORMATION AND PROPAGATION OF GLYCATION.
P. Chellan and R. H. Nagaraj (2001)
J. Biol. Chem. 276, 3895-3903
   Abstract »    Full Text »    PDF »
Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products.
N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama (2001)
J. Biol. Chem. 276, 13348-13355
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)